What is the current price and intraday range for 2228.HK stock?

The 2228.HK stock trades at **HK$9.91** intraday on 10 Mar 2026. Today’s range is **HK$9.77** to **HK$10.08** with volume of **25,682,300** shares and market cap about **HK$41.91B**.

What price target does Meyka AI give for 2228.HK stock?

Meyka AI's forecast model projects **HK$10.66** for one year and **HK$11.76** quarterly. The one-year implied upside from **HK$9.91** is **7.45%**. Forecasts are model-based projections and not guarantees.

What are the main valuation metrics for 2228.HK stock?

Reported EPS is **1.05** with a P/E of **9.28** and price/book **4.63**. Price/sales is high at **54.35**, while free cash flow per share is negative at **-0.13** HKD, indicating valuation depends on future revenue growth.

When is the next earnings report for 2228.HK stock?

XtalPi has an earnings announcement scheduled for **25 Mar 2026**. Investors should watch revenue trends, cash flow, and management guidance for AI-driven drug discovery progress.

HK Stocks

HK$9.91 intraday: XtalPi Holdings (2228.HK) on HKSE 10 Mar 2026: 7.45% upside

ByHuzaifa Zahoor March 10, 2026

The 2228.HK stock trades at HK$9.91 intraday on 10 Mar 2026 on the HKSE, down 1.49% from yesterday. Volume is 25,682,300 shares, below the 50-day average price but above short-term flows. Investors watching AI-driven drug discovery firms should note XtalPi Holdings Ltd (2228.HK) mixes solid cash buffers with volatile revenue metrics. We examine valuation, technicals, Meyka AI forecasts, and sector context for a clear trading view.